After UnitedHealthcare CEO Brian Thompson was shot to death in December, law enforcement records show a burst of police ...
The industry says it keeps down the cost of prescription drugs, but critics say it's profiting at the expense of patients.
From 2017 to 2022, the companies marked up prices at their pharmacies by hundreds or thousands of percent, netting them $7.3 billion in revenue.
Insurer-pharmacy benefit manager (PBM) firms control most of the Medicare Part D market, steering patients to their ...
FTC report reveals significant markups by top PBMs on specialty drugs, driving $7.3 billion in revenue and raising costs for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback